John Lomoro is the Chief Financial Officer of Biotia, a New York-based health tech company building AI-powered infectious disease diagnostics from next-generation sequencing data. As CFO, he leads financial strategy, capital planning, financial reporting, and operational finance across the company.

He oversees budgeting and financial controls supporting Biotia's clinical metagenomic diagnostic assays, including the BIOTIA-DX assay, the BIOTIA-ID Urine Test, the BIOTIA-ID Joint Fluid Test, and the GeoSeeq global outbreak surveillance platform. He works closely with Biotia's CEO and leadership team on growth strategy, fundraising, and partnerships with investors and commercial partners.